Trifluridine/Tipiracil plus Bevacizumab in Patients with Untreated Metastatic Colorectal Cancer Ineligible for Intensive Therapy: the Randomized TASCO1 Study
Van Cutsem, E., Danielewicz, I., Saunders, M.P., Pfeiffer, P., Argilés, G., Borg, C., Glynne-Jones, R., Punt, C.J.A., Van de Wouw, A.J., Fedyanin, M., Stroyakovskiy, D., Kroening, H., Garcia-Alfonso,Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.05.024
Date:
June, 2020
File:
PDF, 2.74 MB
2020
File converter
More search results
More benefits 
